Venetoclax plus intensive chemotherapy with cladribine, idarubicin, and cytarabine in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a cohort from a single-centre, single-arm, phase 2 trial

Tapan M. Kadia, Patrick K. Reville, Gautam Borthakur, Musa Yılmaz, Steven M. Kornblau, Yesid Alvarado, Courtney D. DiNardo, Naval Daver, Nitin Jain, Naveen Pemmaraju, Nicholas J. Short, Sa A. Wang, Rebecca S. Tidwell, Rabiul Islam, Marina Konopleva, Guillermo Garcia‐Manero, Farhad Ravandi, Hagop M. Kantarjian